Skip to main content
$108.55 -$0.23 (-0.2%)

04:00 PM EST on 01/14/22

Medtronic (NYSE:MDT)

CAPS Rating: 4 out of 5

Current Price $108.55 Mkt Cap $146.0B
Open $108.09 P/E Ratio 31.05
Prev. Close $108.55 Div. (Yield) $2.52 (2.3%)
Daily Range $107.24 - $108.85 Volume 6,291,571
52-Wk Range $98.38 - $135.89 Avg. Daily Vol. 8,058,613

Caps

How do you think NYSE:MDT will perform against the market?

Add Stock to CAPS Watchlist

All Players

87 Outperform
1 Underperform
 

All-Star Players

15 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:MDT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

desharr1 (58.65)
Submitted December 29, 2021

Has been pummeled but has good products

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NYSE:MDT VS S&P 500 (SPY)

NYSE:MDT Summary

Fools bullish on NYSE:MDT are also bullish on:

Fools bearish on NYSE:MDT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MDT.

Recs

1
Member Avatar desharr1 (58.65) Submitted: 12/29/2021 1:57:49 PM : Outperform Start Price: $104.28 NYSE:MDT Score: +6.84

Has been pummeled but has good products

Recs

1
Member Avatar TMFkodyk123 (29.94) Submitted: 7/23/2021 2:13:56 PM : Outperform Start Price: $127.96 NYSE:MDT Score: -20.75

Medtronic is positioned to benefit from an aging global population and strong demand for healthcare going forward as a result. The company's commitment to innovation and steady launch of quality products to address serious medical conditions should help deliver mid-single-digit annual revenue growth and high-single-digit annual earnings growth in the years ahead, which will outperform the S&P 500 considering the company is trading near fair value and offers a 2% dividend yield.

Recs

0
Member Avatar TMFjimhalley (< 20) Submitted: 5/31/2021 3:15:42 PM : Outperform Start Price: $126.81 NYSE:MDT Score: -24.29

The company has seen strong growth in revenue in the most recent quarter, meaning that it is poised to do better this year as more medical procedures are performed after a year when they were delayed because of COVID-19. Also, the company's emphasis on diabetes care has trends in its favor.

Leaderboard

Find the members with the highest scoring picks in MDT.

Score Leader

TheFall2021

TheFall2021 (92.15) Score: +31.18

The Score Leader is the player with the highest score across all their picks in MDT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TheFall2021 92.15 12/21/2020 Underperform 5Y $113.01 -3.85% +27.34% +31.18 0 Comment
desharr1 58.65 12/29/2021 Outperform 5Y $104.28 +4.21% -2.64% +6.84 1 Comment
AxeCapital11 31.70 1/4/2022 Outperform 5Y $105.73 +2.77% -3.02% +5.79 0 Comment
Jeffrey82 24.46 1/4/2022 Outperform 5Y $106.54 +1.99% -2.74% +4.74 0 Comment
dvdabbledec2021 61.94 1/6/2022 Outperform 5Y $105.35 +3.14% -0.90% +4.04 0 Comment
FerN45hDlT 34.88 11/29/2021 Outperform 5Y $112.00 -2.98% +0.14% -3.13 0 Comment
aldsectors 63.04 11/16/2021 Outperform 5Y $117.30 -7.37% -0.52% -6.85 0 Comment
Boat6458 38.67 11/4/2021 Outperform 5Y $121.60 -10.64% -0.13% -10.51 0 Comment
aldwords2020 47.51 10/26/2021 Outperform 5Y $124.22 -12.53% +1.65% -14.18 0 Comment
IMGNE < 20 10/19/2021 Outperform 5Y $122.05 -10.97% +3.23% -14.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MDT.